Rossari Biotech Limited — Board Meeting, 21-01-2025: Outcome of Board Meeting

At the recent board meeting, the key outcomes included the approval of unaudited financial results for the quarter and nine months ended December 31, 2024. Revenue from operations was reported at ₹36.83 crore, showing a solid growth trajectory. The board also approved the relocation of the company's registered office within Mumbai effective February 1, 2025. Furthermore, 7,500 equity shares were allotted under the Rossari Employee Stock Option Plan - 2019, raising the total paid-up equity share capital to ₹110.73 crore. Additionally, M/s. Shah Patel & Associates was appointed as the Secretarial Auditor for the financial year 2024-25.